Growth Factors (GF) are molecules used in the clean meat and cell therapy industries. Both industries suffer from the same problem: the sky-high cost of GF at 2M€/g.
With the GF market predicted to grow by 1-2 orders of magnitude in the next 3-5 years, this is a massive opportunity.
Core Biogenesis are using plants as biofactories to produce GF 10x cheaper.
They use proprietary gene editing and plant biotechnology to drastically reduce the cost of making GF.
They have already signed a €250k contract with a pharmaceutical company and have more than 15 companies waiting to test their molecules in their pipeline.